We are live on ! Find out more
KIDS icon

OrthoPediatrics

119 hedge funds and large institutions have $317M invested in OrthoPediatrics in 2026 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 52 increasing their positions, 32 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 32

22% more capital invested

Capital invested by funds: $259M → $317M (+$57.7M)

0.09% less ownership

Funds ownership: 64.52% → 64.43% (-0.09%)

6% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 17

2% less funds holding

Funds holding: 121 → 119 (-2)

Holders
119
Holders Change
-2
Holders Change %
-1.65%
% of All Funds
1.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
52
Reduced
32
Closed
17
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$144K

KIDS Hedge Fund Activity: Q2 2026 in Review

119 of the 8,351 institutional investors tracked by Wall St. Rank reported a position in OrthoPediatrics (KIDS) for Q2 2026, worth a combined $317M — up 22% from $259M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of KIDS and 16 opened new positions — a net loss of 1 holder — while 32 trimmed existing stakes and 52 added.

The largest buyer was AIGH Capital Management, opening a new position worth an estimated $4.69M. The largest seller was Morgan Stanley, cutting an estimated $7.78M.

  • 119 institutional investors held OrthoPediatrics (KIDS) as of Q2 2026, down from 121 in Q1 2026.
  • Funds reported $317M of OrthoPediatrics stock for Q2 2026, up 22% quarter-over-quarter.
  • 16 funds opened new OrthoPediatrics positions in Q2 2026 and 17 closed out, a net change of -1 holder.
  • The largest OrthoPediatrics buyer in Q2 2026 was AIGH Capital Management, an estimated $4.69M added.
  • The largest OrthoPediatrics seller in Q2 2026 was Morgan Stanley, an estimated $7.78M sold.

Based on aggregated 13F filings for Q2 2026.